Pharma giant Pfizer announced on Tuesday that it’s working with BioNTech, a German company working on new kinds of immunotherapy treatments, on a potential COVID-19 vaccine. The joint effort, confirmed Tuesday via a signed letter of intent, will see both partners work together on a a messenger RNA-based vaccine that will seek to prevent people […]...